Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Power List / 2019 / Business Captains / John Chiminski

John Chiminski

President and Chief Executive Officer, Catalent

  • Profile

Meet John Chiminski

“Honestly, I wish I could’ve known that as an electrical engineer, I would one day be working in the pharma and biotech industry. Although my engineering background has served me well, I would have spent more time learning the life sciences disciplines of biology and chemistry! What drives me? Being responsible for 1,000 customers and more than 11,000 employees at Catalent. The patient is the common factor behind both of these groups and ensures that our priorities and decisionmaking deliver safe and effective medicines. I would like to see more standardization of regulatory requirements across all global agencies. There are still significant differences in requirements, and how inspectors interpret these requirements through their inspections, that lead to ‘patch-work’ solutions and processes. This, in turn, leads to variability and additional costs that don’t necessarily equate to better quality or control.”

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.